|
|||||
|
|
Resistance to activated protein C, highly prevalent amongst users of oral contraceptives with venous thromboembolism |
|
| Authors: | L. Bennet,& H. Odeberg |
| Affiliation: | From the Medicinkliniken, Blekinge Hospital, Karlskrona, Sweden |
| Abstract: | |
| Keywords: | activated protein C resistance factor V gene mutation oral contraceptives prevalence thromboembolic risk situation venous thromboembolism |